On the evolution of the company we keep: Implications for infectious disease modeling
PLOS Medicine · 13.05.2026 · 23 (5) · e1005075
DOI: 10.1371/journal.pmed.1005075 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Medicine, online erschienen am 13.05.2026. Verfasst von Joël Mossong. Beteiligte Einrichtung: Health Directorate, Ministry of Health and Social Security, Luxembourg, Luxembourg. Hauptthemen laut MEDLINE: Communicable Diseases, Epidemiological Models. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Health Directorate, Ministry of Health and Social Security, Luxembourg, Luxembourg.
ORCID-Profile: Joël Mossong
Zitieren
APA
Mossong, J. (2026). On the evolution of the company we keep: Implications for infectious disease modeling. PLOS Medicine, 23(5), e1005075. https://doi.org/10.1371/journal.pmed.1005075
Vancouver
Mossong J. On the evolution of the company we keep: Implications for infectious disease modeling. PLOS Medicine. 2026;23(5):e1005075. doi:10.1371/journal.pmed.1005075
BibTeX
@article{Mossong2026,
author = {Mossong, Joël},
title = {On the evolution of the company we keep: Implications for infectious disease modeling},
journal = {PLOS Medicine},
year = {2026},
volume = {23},
number = {5},
pages = {e1005075},
doi = {10.1371/journal.pmed.1005075}
}
EUVIMED